Biological effects of Byrsocarpus coccineus in vitro

References

• Adjanohoun EJ, Ahyi AMR, Ake Assi L, Akpagana K, Chibon P, El-Hadji A, Eyme J, Garba M, Gassita JN, Gbeassor M, Goudote E, Guinko S, Houdoto KK, Houngnon P, Keita A, Keoula A, KlugoOcloo WP, Lo I, Siamevi KM, Taffame KK. (1986). Contribution to ethnobotanical and floristic studies in Togo. Agency for Cultural and Technical Cooperation (ACCT). Paris: Traditional Medicine and Pharmacopoeia, 671.
   Google Scholar
• Agbonon A, Eklu-Gadegbeku K, Aklikokou K, Gbeassor M, Akpagana K, Tam TW, Arnason JT, Foster BC. (2010). In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily. J Ethnopharmacol, 128, 390–394.
   PubMed Web of Science ®Google Scholar
• Akindele AJ, Adeyemi OO. (2006a). Analgesic activity of the aqueous leaf extract of Byrsocarpus coccineus. Niger J Health Biomed Sci, 5, 43–47.
   Google Scholar
• Akindele AJ, Adeyemi OO. (2006b). Evaluation of the antidiarrhoeal activity of Byrsocarpus coccineus. J Ethnopharmacol, 108, 20–25.
   PubMed Web of Science ®Google Scholar
• Akindele AJ, Adeyemi OO. (2007). Antipyretic activity of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae). Int J Pharmacol, 3, 357–361.
   Google Scholar
• Akindele AJ, Adeyemi OO. (2010). Anxiolytic and sedative effects of Brysocarpus coccineus Schum. and Thonn. (Connaraceae). Int J Appl Res Nat Prod, 3, 28–36.
   Google Scholar
• Ameer B, Weintraub RA. (1997). Drug interactions with grapefruit juice. Clin Pharmacokinet, 33, 103–121.
   PubMed Web of Science ®Google Scholar
• Bailey DG, Malcolm J, Arnold O, Spence JD. (1998). Grapefruit juice−drug interactions. Br J Clin Pharmacol, 46, 101–110.
   PubMed Web of Science ®Google Scholar
• Briskin DP. (2000). Medicinal plants and phytomedicines: Linking plant biochemistry and physiology to human health. Plant Physiol, 124, 507–514.
   PubMed Web of Science ®Google Scholar
• Burkill HM. (1985). The Useful Plants of West Tropical Africa, Vol. 1, second edition. Families A–D. Kew, UK: Royal Botanic Gardens, pp. 446–447.
   Google Scholar
• Clark JI, Weiner LM. (1995). Biologic treatment of human cancer. Curr Probl Cancer, 19, 185–262.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Koebel CM, Scheiber RD. (2006). Interferons, immunity and cancer immunoediting. Nat Rev Immunol, 6, 836–848.
   PubMed Web of Science ®Google Scholar
• Eksioglu EA, Bess JR, Zhu H, Xu Y, Dong H-J Elyar, J, Nelson DR, Liu C. (2009). Hepatitis C virus modulates human monocyte-derived dendritic cells. J Viral Hepat. 10.1111/j.1365-2893.2009.01231.x.
   Web of Science ®Google Scholar
• Gaudineau C, Beckerman R, Welbourn S, Auclair K. (2004). Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem Biophys Res Commun, 318, 1072–1078.
   PubMed Web of Science ®Google Scholar
• Gilewski TA, Golomb HM. (1990). Design of combination biotherapy studies: Future goals and challenges. Semin Oncol, 17, S3–10.
   PubMed Web of Science ®Google Scholar
• Girennavar B, Jayaprakasha GK, Patil BS. (2007). Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. J Food Sci, 72, C417–C421.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Chun Y-J Kim, D, Gillam EMJ, Shimada T. (2003). Cytochrome P450 1B1: A target for inhibition in anticarcinogenesis strategies. Mutat Res, 523-524, 173–182.
   PubMed Web of Science ®Google Scholar
• Hilkens CMU, Schlaak JF, Kerr IM. (2003). Differential responses to IFN-α subtypes in human T cells and dendritic cells. J. Immunol, 171, 5255–5263.
   PubMed Web of Science ®Google Scholar
• Huber WW, Rossmanith W, Grusch M, Haslinger E, Prustomersky S, Peter-Vorosmarty B, Parzefall W, Scharf G, Schulte-Hermann R. (2008). Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 46, 1230–1238.
   PubMed Web of Science ®Google Scholar
• Issa AY, Volate SR, Wargovich MJ. (2006). The role of phytochemicals in inhibition of cancer and inflammation: New directions and perspectives. J Food Comp Anal, 19, 405–419.
   Web of Science ®Google Scholar
• Khan OA, Jiang H, Subramaniam PS, Johnson HM, Dhib-Jalbut SS. (1998). Immunomodulating functions of recombinant ovine interferon tau: Potential for therapy in multiple sclerosis and autoimmune disorders. Mult Scler, 4, 63–69.
   PubMed Web of Science ®Google Scholar
• Kupferschmidt HHT, Fattinger KE, Ha HR, Follath R, Krahenbuhl S. (1998). Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol, 45, 355–359.
   PubMed Web of Science ®Google Scholar
• Neuwinger HD. (1996). African Ethnobotany: Poisons and Drugs; Chemistry, Pharmacology and Toxicology. Weinheim, Germany: Chapman & Hall, pp. 377–379.
   Google Scholar
• Niwat T, Shiraga T, Yamasaki S, Ishibashi K, Ohno Y, Kagayama A. (2003). In vitro activation of 7-benzyloxyresoruin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica, 33, 717–729.
   PubMed Web of Science ®Google Scholar
• Pekthong D, Martin H, Abadie C, Bonet A, Heyd B, Mantion G, Richert L. (2008). Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide. J Ethnopharmacol, 115, 432–440.
   PubMed Web of Science ®Google Scholar
• Peters M. (1996). Actions of cytokines on the immune response and viral interactions: An overview. Hepatology, 23, 909–916.
   PubMed Web of Science ®Google Scholar
• Pohl RJ, Fouts JR. (1980). A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem, 107, 150–155.
   PubMed Web of Science ®Google Scholar
• Prough RA, Burke MD, Mayer RT. (1978). Direct fluorometric methods for measuring mixed-function oxidase activity. Methods Enzymol, 52, 372–377.
   PubMedGoogle Scholar
• Renwick AB, Surry D, Price RJ, Lake BG, Evans DC. (2000). Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms. Xenobiotica, 30, 955–969.
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Büschel B, Kirch W. (2003). Unwanted pregnancy on self-medication with St. John’s wort despite hormonal contraception. Br J Clin Pharmacol, 55, 112–113.
   PubMed Web of Science ®Google Scholar
• Shakeel M, Trinidade A, McCluney N, Clive B. (2010). Complementary and alternative medicine in epistaxis: A point worth considering during the patient’s history. Eur J Emerg Med, 17, 17–19.
   PubMed Web of Science ®Google Scholar
• Stresser DM, Blanchard AP, Turner SD, Erve JCL, Dandeneau AA, Miller VP, Crespi CL. (2000). Substrate-dependent modulation of CYP3A4 catalytic activity: Analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos, 28, 1440–1448.
   PubMed Web of Science ®Google Scholar
• Uematsu S, Akira S. (2007). Toll-like receptors and type I interferons. J Biol Chem, 282, 15319–15323.
   PubMed Web of Science ®Google Scholar
• Ueng Y-F Kuwabara, T, Chun Y-J Guengerich, FP. (1997). Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry, 36, 370–381.
   PubMed Web of Science ®Google Scholar
• Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. (1995). The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol, 37, 7–15.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol, 22, 1–21.
   PubMed Web of Science ®Google Scholar
• Zhou S-F Xue, CC, Yu X-Q Li, C, Wang G. (2007). Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit, 29, 687–710.
   PubMed Web of Science ®Google Scholar